0001645842-22-000028.txt : 20220303
0001645842-22-000028.hdr.sgml : 20220303
20220303183357
ACCESSION NUMBER: 0001645842-22-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kimball Aaron
CENTRAL INDEX KEY: 0001845645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40354
FILM NUMBER: 22711050
MAIL ADDRESS:
STREET 1: 5980 HORTON ST., STE 105
CITY: EMERYVILLE
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymergen Inc.
CENTRAL INDEX KEY: 0001645842
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 462942439
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5980 HORTON STREET, SUITE 105
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (415) 801-8073
MAIL ADDRESS:
STREET 1: 5980 HORTON STREET, SUITE 105
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Zymergen, Inc.
DATE OF NAME CHANGE: 20150622
4
1
wf-form4_164635040182939.xml
FORM 4
X0306
4
2022-03-01
0
0001645842
Zymergen Inc.
ZY
0001845645
Kimball Aaron
5980 HORTON STREET, SUITE 105
EMERYVILLE
CA
94608
0
1
0
0
Chief Technology Officer
Common Stock
2022-03-01
4
S
0
25000
3.8138
D
745283
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
Transaction executed in multiple trades at prices ranging from $3.76 to $3.92 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Natalie Dement, attorney-in-fact
2022-03-03